A triplet chemotherapy regimen of cisplatin, fluorouracil and paclitaxel for locoregionally recurrent nasopharyngeal carcinoma cases contraindicated for re-irradiation/surgery-Reference-Cited by-同舟云学术

A triplet chemotherapy regimen of cisplatin, fluorouracil and paclitaxel for locoregionally recurrent nasopharyngeal carcinoma cases contraindicated for re-irradiation/surgery

Published:2016-06-30 Issue:12 Volume:17 Page:1585-1590
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Wang Yun¹²,Wang Zhi-qiang¹²,Jiang Yuan-xue¹²,Wang Feng-hua¹²,Luo Hui-yan¹²,Liang Ying¹²,Wang De-shen¹²,Li Yu-hong¹²

Affiliation:

1. State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, P.R. China

2. Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2016.1204293

Reference25 articles.

1. Nasopharyngeal Carcinoma

2. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976–1985: Overall survival and patterns of failure

3. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma

4. Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma

5. Long term results of radioactive gold grain implantation for the treatment of persistent and recurrent nasopharyngeal carcinoma

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial;European Journal of Cancer;2023-11

2. Treatment of loco-regional recurrence of nasopharyngeal carcinoma in a non-endemic area: oncologic outcomes, morbidity, and proposal of a prognostic nomogram;Frontiers in Oncology;2023-05-16

3. Treatment of Recurrent Nasopharyngeal Carcinoma: A Sequential Challenge;Cancers;2022-08-25

4. Endoscopic surgery is superior to intensity‐modulated radiotherapy in the treatment of advanced recurrent nasopharyngeal carcinoma;International Forum of Allergy & Rhinology;2022-07-21

5. NSUN2 Promotes Tumor Progression and Regulates Immune Infiltration in Nasopharyngeal Carcinoma;Frontiers in Oncology;2022-04-29